Gilead Sciences
GILD
1,326 hedge funds and large institutions have $139B invested in Gilead Sciences in 2014 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 465 increasing their positions, 615 reducing their positions, and 51 closing their positions.
147% more first-time investments, than exits
New positions opened: 126 | Existing positions closed: 51
46% more funds holding in top 10
Funds holding in top 10: 164 → 240 (+76)
20% more capital invested
Capital invested by funds: $116B → $139B (+$22.7B)
5% more funds holding
Funds holding: 1,262 → 1,326 (+64)
24% less repeat investments, than reductions
Existing positions increased: 465 | Existing positions reduced: 615
36% less call options, than puts
Call options by funds: $2.53B | Put options by funds: $3.96B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$226M |
| 2 |
D.E. Shaw & Co
New York
|
+$223M |
| 3 |
Barclays
London,
United Kingdom
|
+$183M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$177M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$143M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.52B |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$1.19B |
| 3 |
Goldman Sachs
New York
|
-$1.17B |
| 4 |
Norges Bank
Oslo,
Norway
|
-$910M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$792M |
GILD Hedge Fund Activity: Q3 2014 in Review
1,326 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q3 2014, worth a combined $139B — up 20% from $116B a quarter earlier.
Buyers outnumbered sellers: 126 funds opened new GILD positions and 51 closed out — a net gain of 75 holders — while 465 added to existing stakes and 615 trimmed.
The largest buyer was BNP Paribas Financial Markets, adding an estimated $226M. The largest seller was Capital Research Global Investors, cutting an estimated $1.52B.
- 1,326 institutional investors held Gilead Sciences (GILD) as of Q3 2014, up from 1,262 in Q2 2014.
- Funds reported $139B of Gilead Sciences stock for Q3 2014, up 20% quarter-over-quarter.
- 126 funds opened new Gilead Sciences positions in Q3 2014 and 51 closed out, a net change of +75 holders.
- The largest Gilead Sciences buyer in Q3 2014 was BNP Paribas Financial Markets, an estimated $226M added.
- The largest Gilead Sciences seller in Q3 2014 was Capital Research Global Investors, an estimated $1.52B sold.
Based on aggregated 13F filings for Q3 2014.